Guided by our key cultural value of Courageous CaringTM and
driven by a sense of urgency, we are building an innovative
biopharma company that invests in, develops and
commercializes life-changing drug therapies.

See Our Advantage


ACELYRIN Announces Appointment of Patrick Machado, JD to Board of Directors
June 10, 2021

Mr. Machado has more than two decades of experience growing biopharmaceutical organizations from development through commercialization...

ACELYRIN Appoints Paul M. Peloso, MD, as Chief Medical Officer
May 25, 2021

ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development...

Dr. Shao-Lee Lin and Bob Carey talk strategy and more at ACELYRIN
March 24, 2021

We recently sat down with ACELYRIN CEO Shao-Lee Lin, MD, PhD and President and COO Bob Carey to talk about the company’s strategy, upcoming milestones, and its intense focus on patients.

Courageous Caring in the Age of COVID
March 4, 2021

Throughout her career, Shao-Lee Lin, MD, PhD has always been driven by a personal mission to make a meaningful difference in patients’ lives.